Enhanced desensitization and phosphorylation of the β1-adrenergic receptor in rat adipocytes by peroxovanadate

Suleiman Bahouth, Yesim Gokmen-Polar, Elizabeth C. Coronel, John N. Fain

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Peroxovanadate (PVN) is an insulin-like agent that inhibits the dephosphorylation of the insulin receptor kinase. PVN inhibited the lipolytic action of 0.1 μM isoproterenol by 88%, which is a relatively specific β1 catecholamine agonist at this concentration, but was largely ineffective against β3 agonists or forskolin. To determine whether PVN-mediated desensitization of the β1AR was associated with enhanced phosphorylation, we immunoprecipitated the β1AR from rat adipocytes that were metabolically labeled with 32PO4. Isoproterenol enhanced the net phosphorylation of the β1AR by 8 ± 2-fold over control. PVN increased the net phosphorylation of the β1AR by 5 ± 0.5-fold, and together with isoproterenol, they enhanced the phosphorylation of the β1AR by 2-fold over isoproterenol alone. Phosphoamino acid analysis of the phosphorylated receptor revealed phosphate incorporation into serine that was proportional to the radioactivity incorporated into the immunoprecipitated receptor. PVN inhibited the serine/threonine phosphatase calcineurin, suggesting that inhibition of receptor dephosphorylation may play a role in the actions of PVN. Cyanogen bromide cleavage of the phosphorylated β1AR generated a phosphoprotein with a molecular mass consistent with carboxyl-terminal phosphorylation. Furthermore, the magnitude of receptor phosphorylation by isoproterenol was 3-fold larger than that due to forskolin, suggesting that the β1AR is a substrate for the βAR kinase that phosphorylates carboxyl-terminal residues in the β2AR. Our findings suggest that PVN may be a powerful new tool with which to study the phosphorylation of other G protein-coupled receptors.

Original languageEnglish (US)
Pages (from-to)1049-1057
Number of pages9
JournalMolecular Pharmacology
Volume49
Issue number6
StatePublished - Jun 1996

Fingerprint

Adipocytes
Adrenergic Receptors
Phosphorylation
Isoproterenol
Colforsin
Phosphotransferases
Phosphoamino Acids
Cyanogen Bromide
Calcineurin
Phosphoprotein Phosphatases
Phosphoproteins
Insulin Receptor
G-Protein-Coupled Receptors
peroxovanadate
Radioactivity
Serine
Catecholamines
Phosphates
Insulin

All Science Journal Classification (ASJC) codes

  • Pharmacology

Cite this

Enhanced desensitization and phosphorylation of the β1-adrenergic receptor in rat adipocytes by peroxovanadate. / Bahouth, Suleiman; Gokmen-Polar, Yesim; Coronel, Elizabeth C.; Fain, John N.

In: Molecular Pharmacology, Vol. 49, No. 6, 06.1996, p. 1049-1057.

Research output: Contribution to journalArticle

Bahouth, Suleiman ; Gokmen-Polar, Yesim ; Coronel, Elizabeth C. ; Fain, John N. / Enhanced desensitization and phosphorylation of the β1-adrenergic receptor in rat adipocytes by peroxovanadate. In: Molecular Pharmacology. 1996 ; Vol. 49, No. 6. pp. 1049-1057.
@article{b8dec665738f43a9a4e1da9f69ceeb92,
title = "Enhanced desensitization and phosphorylation of the β1-adrenergic receptor in rat adipocytes by peroxovanadate",
abstract = "Peroxovanadate (PVN) is an insulin-like agent that inhibits the dephosphorylation of the insulin receptor kinase. PVN inhibited the lipolytic action of 0.1 μM isoproterenol by 88{\%}, which is a relatively specific β1 catecholamine agonist at this concentration, but was largely ineffective against β3 agonists or forskolin. To determine whether PVN-mediated desensitization of the β1AR was associated with enhanced phosphorylation, we immunoprecipitated the β1AR from rat adipocytes that were metabolically labeled with 32PO4. Isoproterenol enhanced the net phosphorylation of the β1AR by 8 ± 2-fold over control. PVN increased the net phosphorylation of the β1AR by 5 ± 0.5-fold, and together with isoproterenol, they enhanced the phosphorylation of the β1AR by 2-fold over isoproterenol alone. Phosphoamino acid analysis of the phosphorylated receptor revealed phosphate incorporation into serine that was proportional to the radioactivity incorporated into the immunoprecipitated receptor. PVN inhibited the serine/threonine phosphatase calcineurin, suggesting that inhibition of receptor dephosphorylation may play a role in the actions of PVN. Cyanogen bromide cleavage of the phosphorylated β1AR generated a phosphoprotein with a molecular mass consistent with carboxyl-terminal phosphorylation. Furthermore, the magnitude of receptor phosphorylation by isoproterenol was 3-fold larger than that due to forskolin, suggesting that the β1AR is a substrate for the βAR kinase that phosphorylates carboxyl-terminal residues in the β2AR. Our findings suggest that PVN may be a powerful new tool with which to study the phosphorylation of other G protein-coupled receptors.",
author = "Suleiman Bahouth and Yesim Gokmen-Polar and Coronel, {Elizabeth C.} and Fain, {John N.}",
year = "1996",
month = "6",
language = "English (US)",
volume = "49",
pages = "1049--1057",
journal = "Molecular Pharmacology",
issn = "0026-895X",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "6",

}

TY - JOUR

T1 - Enhanced desensitization and phosphorylation of the β1-adrenergic receptor in rat adipocytes by peroxovanadate

AU - Bahouth, Suleiman

AU - Gokmen-Polar, Yesim

AU - Coronel, Elizabeth C.

AU - Fain, John N.

PY - 1996/6

Y1 - 1996/6

N2 - Peroxovanadate (PVN) is an insulin-like agent that inhibits the dephosphorylation of the insulin receptor kinase. PVN inhibited the lipolytic action of 0.1 μM isoproterenol by 88%, which is a relatively specific β1 catecholamine agonist at this concentration, but was largely ineffective against β3 agonists or forskolin. To determine whether PVN-mediated desensitization of the β1AR was associated with enhanced phosphorylation, we immunoprecipitated the β1AR from rat adipocytes that were metabolically labeled with 32PO4. Isoproterenol enhanced the net phosphorylation of the β1AR by 8 ± 2-fold over control. PVN increased the net phosphorylation of the β1AR by 5 ± 0.5-fold, and together with isoproterenol, they enhanced the phosphorylation of the β1AR by 2-fold over isoproterenol alone. Phosphoamino acid analysis of the phosphorylated receptor revealed phosphate incorporation into serine that was proportional to the radioactivity incorporated into the immunoprecipitated receptor. PVN inhibited the serine/threonine phosphatase calcineurin, suggesting that inhibition of receptor dephosphorylation may play a role in the actions of PVN. Cyanogen bromide cleavage of the phosphorylated β1AR generated a phosphoprotein with a molecular mass consistent with carboxyl-terminal phosphorylation. Furthermore, the magnitude of receptor phosphorylation by isoproterenol was 3-fold larger than that due to forskolin, suggesting that the β1AR is a substrate for the βAR kinase that phosphorylates carboxyl-terminal residues in the β2AR. Our findings suggest that PVN may be a powerful new tool with which to study the phosphorylation of other G protein-coupled receptors.

AB - Peroxovanadate (PVN) is an insulin-like agent that inhibits the dephosphorylation of the insulin receptor kinase. PVN inhibited the lipolytic action of 0.1 μM isoproterenol by 88%, which is a relatively specific β1 catecholamine agonist at this concentration, but was largely ineffective against β3 agonists or forskolin. To determine whether PVN-mediated desensitization of the β1AR was associated with enhanced phosphorylation, we immunoprecipitated the β1AR from rat adipocytes that were metabolically labeled with 32PO4. Isoproterenol enhanced the net phosphorylation of the β1AR by 8 ± 2-fold over control. PVN increased the net phosphorylation of the β1AR by 5 ± 0.5-fold, and together with isoproterenol, they enhanced the phosphorylation of the β1AR by 2-fold over isoproterenol alone. Phosphoamino acid analysis of the phosphorylated receptor revealed phosphate incorporation into serine that was proportional to the radioactivity incorporated into the immunoprecipitated receptor. PVN inhibited the serine/threonine phosphatase calcineurin, suggesting that inhibition of receptor dephosphorylation may play a role in the actions of PVN. Cyanogen bromide cleavage of the phosphorylated β1AR generated a phosphoprotein with a molecular mass consistent with carboxyl-terminal phosphorylation. Furthermore, the magnitude of receptor phosphorylation by isoproterenol was 3-fold larger than that due to forskolin, suggesting that the β1AR is a substrate for the βAR kinase that phosphorylates carboxyl-terminal residues in the β2AR. Our findings suggest that PVN may be a powerful new tool with which to study the phosphorylation of other G protein-coupled receptors.

UR - http://www.scopus.com/inward/record.url?scp=0030013568&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030013568&partnerID=8YFLogxK

M3 - Article

VL - 49

SP - 1049

EP - 1057

JO - Molecular Pharmacology

JF - Molecular Pharmacology

SN - 0026-895X

IS - 6

ER -